The Medical Marijuana Industry is Closely Monitoring Congress’ Budget Bills to Determine the Fate of the Rohrabacher-Farr Amendment
The medical marijuana industry is closely monitoring Congress’ budget bills to determine the fate of the Rohrabacher-Farr amendment. The provision, which dates back to 2014, prohibits the U.S. Department of Justice (DOJ) from using federal funds to interfere with state laws legalizing medical marijuana.
The amendment was first introduced by Reps. Dana Rohrabacher (R-California) and Sam Farr (D-California) as part of a 2014 omnibus spending bill. It states:
None of the funds made available in this Act to the Department of Justice may be used, with respect to the States of Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, Oregon, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Washington, and Wisconsin, to prevent such States from implementing their own State laws that authorize the use, distribution, possession, or cultivation of medical marijuana.
Courts have relied on the amendment to prohibit the federal government from enforcing the Controlled Substances Act so long as entities and individuals comply with state medical marijuana laws. In U.S. v. Marin Alliance for Medical Marijuana, the U.S. District Court for the Northern District of California stated:
The CSA remains in place, and this Court intends to enforce it to the full extent that Congress has allowed in Section 538, that is, with regard to any medical marijuana not in full compliance with “State law [ ] that authorize[s] the use, distribution, possession, or cultivation of medical marijuana.”
Further Extensions of Rohrabacher-Farr Amendment
The Rohrabacher-Farr amendment, which notably only applies to medical marijuana, must be renewed each fiscal year in order to remain in effect. While the extension of the amendment was largely a non-issue over the past several years, the Trump Administration’s hostility to marijuana legalization has put further extensions in jeopardy.
On May 5, 2017, President Trump signed a short-term budget bill extending the Rohrabacher-Farr amendment until September 30, 2017. It also extended its protections to additional states that have passed legalized medical cannabis programs. While this is all good news, the President also issued a “signing statement” commenting on the amendment. It stated:
Division B, section 537 provides that the Department of Justice may not use any funds to prevent implementation of medical marijuana laws by various States and territories. I will treat this provision consistently with my constitutional responsibility to take care that the laws be faithfully executed.
While the intent of President Trump’s signing statement is unclear, U.S. Attorney General Jeff Sessions expressly wrote to Congress, advocating that the amendment not be extended. His letter stated:
I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of a historic drug epidemic and potentially long-term uptick in violent crime. The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.
The House of Representatives has also put up roadblocks. In early September, Republican leaders blocked a vote on the amendment, now known as the Rohrabacher-Blumenauer after co-sponsors Dana Rohrabacher (R-Calif.) and Earl Blumenauer (D-Ore.). “By blocking our amendment, Committee leadership is putting at risk the millions of patients who rely on medical marijuana for treatment, as well as the clinics and businesses that support them,” Rohrabacher and Blumenauer said in a joint statement about the House Rules Committee’s decision.
In a victory for the cannabis industry, Congress ultimately passed a budget bill that extends the Rohrabacher-Blumenauer amendment through December 8, 2017. However, the uncertainty caused by Republican House Leaders and Attorney General Sessions suggests that a long-term legislative solution is needed.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
Demand Letters & Cease and Desist Letters: When to Send One (and When Not To)
Businesses and individuals often encounter situations where another party breaches a contract, fails to pay a debt, or continues harmful conduct. In many such disputes, a precisely drafted demand letter or cease-and-desist letter serves as a powerful legal tool. It can frequently resolve the dispute and avoid litigation. While demand or cease-and-desist letters can resolve […]
Key provisions in your contracts, including those relating to indemnification, insurance, and defense, are essential to contract risk management. While sometimes considered “boilerplate,” these provisions play a pivotal role when determining which party is responsible for certain costs and liabilities. They must always be negotiated and drafted carefully. Indemnification Clauses Businesses should never overlook the […]
Portability of estate and gift tax enables a surviving spouse to inherit any unused portion of their deceased spouse’s federal estate and gift tax exemption. So, if one spouse doesn’t utilize their full exemption, the surviving spouse can effectively double their exemption amount with regard to estate tax liability. For married couples, portability offers a […]
Pet Trusts in New Jersey and New York: A Practical Estate Planning Tool
For many of us, pets are more than companions—they are members of the family. Yet they are often overlooked or inadequately provided for when it comes to estate planning. A pet trust offers a legally enforceable way to ensure that your animal continues to receive proper care if you become incapacitated or pass away. As […]
For many New Jersey business owners, a closely held company represents decades of work, financial investment, and personal sacrifice. Trusts in business succession planning are one of the most effective tools for protecting that value, allowing founders to control how and when the business passes to the next generation while reducing the risk of disputes, […]
Read Before You Sign: IT Contract Pitfalls Every NJ Business Should Know
In today’s digital economy, New Jersey businesses of all sizes rely heavily on technology vendors, software providers, cloud platforms, and managed IT services. Whether your company is purchasing software, migrating data to the cloud, engaging a cybersecurity consultant, or entering into a long-term managed services agreement, a careful IT contract review can have significant operational, […]
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Sign up to get the latest from our attorneys!
Explore What Matters Most to You.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!
